In conclusion, our potentially novel data indicated that the SEMA7AR148W mutation was a novel genetic determinant of NAFLD and that PKC-α signaling–induced FA and TG synthesis and FA uptake were enhanced by the SEMA7AR148W mutation. The gene discussed is PRKCA; the disease is metabolic dysfunction-associated steatotic liver disease.